Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 2
1968 1
1969 5
1970 4
1971 5
1972 4
1973 2
1974 2
1975 2
1976 3
1977 1
1979 3
1982 1
1984 5
1985 5
1986 2
1990 6
1991 5
1992 4
1993 4
1994 4
1995 3
1996 6
1997 4
1998 12
1999 9
2000 6
2001 9
2002 8
2003 14
2004 14
2005 7
2006 12
2007 10
2008 31
2009 24
2010 25
2011 37
2012 34
2013 34
2014 42
2015 32
2016 45
2017 34
2018 32
2019 30
2020 38
2021 37
2022 38
2023 51
2024 20

Search Results

669 results

Results by year

Filters applied: . Clear all
Page 1
Gene Therapy Approaches for the Treatment of Hemophilia B.
Soroka AB, Feoktistova SG, Mityaeva ON, Volchkov PY. Soroka AB, et al. Int J Mol Sci. 2023 Jun 28;24(13):10766. doi: 10.3390/ijms241310766. Int J Mol Sci. 2023. PMID: 37445943 Free PMC article. Review.
Concizumab: First Approval.
Keam SJ. Keam SJ. Drugs. 2023 Jul;83(11):1053-1059. doi: 10.1007/s40265-023-01912-6. Drugs. 2023. PMID: 37341887 Review.
Protein S antibody as an adjunct therapy for hemophilia B.
Wilson HP, Pierre A, Paysse AL, Kumar N, Cooley BC, Rudra P, Dorsey AW, Polania-Villanueva D, Chatterjee S, Janbain M, Velez MC, Majumder R. Wilson HP, et al. Blood Adv. 2024 Jan 23;8(2):441-452. doi: 10.1182/bloodadvances.2023010819. Blood Adv. 2024. PMID: 37773781 Free PMC article.
The More Recent History of Hemophilia Treatment.
Franchini M, Mannucci PM. Franchini M, et al. Semin Thromb Hemost. 2022 Nov;48(8):904-910. doi: 10.1055/s-0042-1756188. Epub 2022 Sep 15. Semin Thromb Hemost. 2022. PMID: 36108649 Review.
Gene therapy for hemophilia, a clinical viewpoint.
Chou SC, Hsu YC, Lin SW. Chou SC, et al. J Formos Med Assoc. 2023 Nov;122(11):1101-1110. doi: 10.1016/j.jfma.2023.05.008. Epub 2023 May 18. J Formos Med Assoc. 2023. PMID: 37210312 Free article. Review.
Inhibitors in Hemophilia B.
Santoro C, Quintavalle G, Castaman G, Baldacci E, Ferretti A, Riccardi F, Tagliaferri A. Santoro C, et al. Semin Thromb Hemost. 2018 Sep;44(6):578-589. doi: 10.1055/s-0038-1660817. Epub 2018 Jun 20. Semin Thromb Hemost. 2018. PMID: 29925096 Review.
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial.
Young G, Srivastava A, Kavakli K, Ross C, Sathar J, You CW, Tran H, Sun J, Wu R, Poloskey S, Qiu Z, Kichou S, Andersson S, Mei B, Rangarajan S. Young G, et al. Lancet. 2023 Apr 29;401(10386):1427-1437. doi: 10.1016/S0140-6736(23)00284-2. Epub 2023 Mar 29. Lancet. 2023. PMID: 37003287 Clinical Trial.
669 results